BioLine RX Ltd (BLRX) — Financial Flexibility Index
BioLine RX Ltd (BLRX) has a Financial Flexibility Index of -0.10x as of September 2025. Free cash flow of ILA-2.11 Million (operating CF ILA-2.11 Million minus capex ILA0.00) represents 0% of total liabilities (ILA20.27 Million). Check BioLine RX Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioLine RX Ltd Financial Flexibility Index (2010–2024)
Historical Financial Flexibility Index trend for BioLine RX Ltd across 15 annual periods. See BioLine RX Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BioLine RX Ltd (2010–2024)
Year-by-year free cash flow to debt coverage for BioLine RX Ltd. For the full company profile including market capitalisation, see BLRX market cap overview.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.72x | ILA-43.82 Million | ILA-43.87 Million | ILA25.45 Million | ▼ -291.4% |
| 2023 | -0.44x | ILA-22.31 Million | ILA-22.61 Million | ILA50.70 Million | ▲ +56.6% |
| 2022 | -1.01x | ILA-25.92 Million | ILA-26.24 Million | ILA25.54 Million | ▲ +42.5% |
| 2021 | -1.76x | ILA-23.48 Million | ILA-23.57 Million | ILA13.30 Million | ▼ -92.9% |
| 2020 | -0.91x | ILA-23.11 Million | ILA-23.21 Million | ILA25.26 Million | ▲ +18.3% |
| 2019 | -1.12x | ILA-22.59 Million | ILA-22.67 Million | ILA20.19 Million | ▼ -19.4% |
| 2018 | -0.94x | ILA-13.98 Million | ILA-24.19 Million | ILA14.91 Million | ▲ +53.5% |
| 2017 | -2.02x | ILA-16.31 Million | ILA-20.55 Million | ILA8.08 Million | ▲ +45.4% |
| 2016 | -3.70x | ILA-14.46 Million | ILA-14.51 Million | ILA3.91 Million | ▼ -19.2% |
| 2015 | -3.10x | ILA-11.45 Million | ILA-14.17 Million | ILA3.69 Million | ▲ +4.6% |
| 2014 | -3.25x | ILA-14.30 Million | ILA-14.48 Million | ILA4.40 Million | ▼ -33.5% |
| 2013 | -2.43x | ILA-20.12 Million | ILA-20.23 Million | ILA8.27 Million | ▼ -14.0% |
| 2012 | -2.14x | ILA-19.94 Million | ILA-20.11 Million | ILA9.34 Million | ▼ -32.9% |
| 2011 | -1.61x | ILA-10.94 Million | ILA-11.22 Million | ILA6.81 Million | ▼ -400.3% |
| 2010 | 0.54x | ILA12.12 Million | ILA11.46 Million | ILA22.65 Million | — |